Posts tagged ‘Canada’
We came across this presentation given by S. Natesh, Senior Advisor, Department of Biotechnology, Government of India during the Canada-India Innovation Summit held 20-22 June 2011 at Carlton University, Ottawa. It brings some context to Steven Harper’s recent visit to India. Click here for the document.
TVO covered this issue in a recent blog post. Your thoughts?
For the past several months, opposition parties and scientists have been raising concern over the way the Conservative government in Ottawa is changing Canadian policies towards the funding of scientific research. Below, James Colliander, a professor of mathematics at the University of Toronto, and blogger, expresses his concerns over the changes. In particular, he expresses skepticism over the government’s strategy to create more partnerships between researchers and businesses, and argues the government has not done enough to properly consult scientists on the policy changes.
Click here for the complete article.
Canadian researchers discover promising new treatment for Ebola infection
Canadian research has potential for global impact
OTTAWA, June 13, 2012 /CNW/ – Researchers at the Public Health Agency of Canada’s National Microbiology Laboratory (NML) have developed a new and easy-to-manufacture treatment for Ebola infection, one of the world’s deadliest diseases. The findings were published today in the Science Translational Medicine journal. The Honourable Leona Aglukkaq, Minister of Health, today congratulated the researchers on their important achievement.
“The Harper Government is committed to advancing national and international public health,” said Minister Aglukkaq. “This groundbreaking discovery is a remarkable achievement and exemplifies the world-class research conducted here in Canada.” Zaire Ebola virus is one of the world’s most aggressive viruses. Up to 90 per cent of infections result in death within days of exposure. As there is no approved Ebola vaccine to prevent infection, there is an urgent need for a treatment to improve survival rates after exposure. This new treatment can be effective when administered up to 48 hours after infection.
“Our researchers have seen first hand the terrible effects of the Ebola virus on populations in Africa,” said Dr. Frank Plummer, Chief Science Officer at the Public Health Agency of Canada. “This discovery should pave the way for the development of a new drug that has the potential to save many lives.”
While Ebola does not naturally occur in Canada, there is always a small risk that it could be imported into Canada by an infected traveller. Having a safe and effective treatment option at the ready is important to protect Canadians from that risk.
The NML is Canada’s leading public health infectious disease laboratory and the only facility in Canada that is permitted to study and work with live haemorrhagic fever viruses such as Ebola and other similarly highly infectious and deadly organisms.
For further information: Également offert en français Health Canada Cailin Rodgers Office of the Honourable Leona Aglukkaq Federal Minister of Health (613) 957-0200 Media Relations Public Health Agency of Canada (613) 941-8189 sures!
The 2012 Sanofi BioGENEius Challenge Canada Competition asks youth ‘how will you change the world’ – Toronto’s Top Biotech Whiz Kids AnswerRegional 2012 Sanofi BioGENEius Challenge Canada Competition takes place in Toronto April 18th. The national research competition inspires Canadian youth to pursue future studies and careers in Canada’s $86 billion biotechnology industry
In its 19th year, the “2012 Sanofi BioGENEius Challenge Canada (SBCC)” is coordinated by Bioscience Education Canada and is sponsored by Sanofi Pasteur Limited, Sanofi Canada, the National Research Council Canada (NRC), Canadian Institutes of Health Research (CIHR), Genome Canada, and the Government of Canada’s Youth Awareness Program.
This year, 26 projects compete for the top spot in Toronto and students look at how to boost the immune system of bees, how to use nanotechnology for more sensitive imaging of lung cancers and how to silence the expression of a mutated gene.
The winner of this competition, along with winners from the other eight regional competitions, will enter the national competition, held at the headquarters of the National Research Council in Ottawa on May 7, 2012. Regional competitions have already been held in Montreal (March 30), Winnipeg, MB (April 11), Vancouver, BC (April 16), and will take place in Edmonton, AB (April 18), Saskatoon, SK (April 18), London, ON (April 18), Toronto, ON (April 17/18), Ottawa, ON (April 25), and Moncton, NB (April 25).
For more information click here.
Click here for Indepth article from the Globe & Mail on new trends in Biotechnology funding in Canada.